Related Experiment Video
Updated: Jan 5, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Opioid-induced endocrinopathies
Athanasios Fountas1, Stan Van Uum2, Niki Karavitaki1
1Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK; Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Abstract:
The use of opioids is becoming a global epidemic, leading to a rise in the occurrence and recognition of the effects of opioid drugs on the endocrine system. Nonetheless, opioid-induced endocrinopathies still remain underdiagnosed, mainly because of symptom under-reporting by patients and poor clinician awareness. Hypogonadism is the most well recognised consequence of opioid use, but the inhibitory effects of opioid drugs on the hypothalamo-pituitary-adrenal axis and their negative effects on bone health also require attention. Hyperprolactinaemia might be detected in opioid users, but clinically relevant thyroid dysfunction has not been identified. The effects of opioids on other hormones have not been clearly defined. Assessment of gonadal and adrenal function (particularly if high index of clinical suspicion of hypogonadism or hypoadrenalism) and evaluation of bone health are advised in people that use opiods. Discontinuation or reduction of opioid dose and appropriate hormone replacement are the management approaches that should be considered for hypogonadism and hypoadrenalism. Further research is needed to facilitate the development of evidence-based guidelines on the diagnosis and optimal management of opioid-induced endocrinopathies.
Insights
Opioid use can disrupt hormone regulation, causing underdiagnosed endocrine issues like hypogonadism and adrenal dysfunction. Early assessment and hormone replacement are key for managing these opioid-induced endocrinopathies.
Area of Science:
- Endocrinology
- Pharmacology
- Public Health
Background:
- Opioid use is a global epidemic with significant endocrine consequences.
- Opioid-induced endocrinopathies are often underdiagnosed due to patient and clinician factors.
- Key endocrine effects include hypogonadism, hypothalamo-pituitary-adrenal axis inhibition, and bone health issues.
Purpose of the Study:
- To review the endocrine effects of opioid use.
- To highlight the underdiagnosis of opioid-induced endocrinopathies.
- To discuss diagnostic and management strategies.
Main Methods:
- Literature review of opioid effects on the endocrine system.
- Analysis of recognized and potential hormonal disruptions.
- Discussion of clinical assessment and management approaches.
Main Results:
- Hypogonadism is the most recognized opioid-induced endocrinopathy.
- Inhibitory effects on the hypothalamo-pituitary-adrenal axis and bone health are significant.
- Clinically relevant thyroid dysfunction and hyperprolactinemia are less consistently identified.
Conclusions:
- Assessment of gonadal, adrenal function, and bone health is recommended for opioid users.
- Management involves dose reduction/discontinuation and hormone replacement therapy.
- Further research is needed for evidence-based guidelines on diagnosis and management.
Related Concept Videos
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
The Endocrine System

